Security key
89854M101
TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)
CUSIP: 89854M101
Q3 2023 13F Holders as of 30 Sep 2023
- Security type / class
- Equity / Voting Common Stock, $0.0001 par value per share
- Total 13F shares
- 28,588,231
- Total 13F value
- $73,196,468
- Share change
- +836,612
- SEC-reported price per share
- $2.56
- Number of holders
- 32
- Value change
- +$2,177,876
- Number of buys
- 16
- Number of sells
- 2
- Shares outstanding
- 55,838,719
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2023
Institutions
32
Top holders
10
TCRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2023
Previous quarter: Q2 2023
TScan Therapeutics, Inc. SEC filings
TScan Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89854M101
Recent filing periods:
Ownership snapshot
Top reported holders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2023
13F
3/4/5
Lead comparable stake: 9.4%
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP leads the comparable SEC ownership view at 9.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Lynx1 Capital Management LP
9.4%
EcoR1 Capital, LLC
9%
ADAGE CAPITAL PARTNERS GP, L.L.C.
7.2%
BVF INC/IL
5.4%
BAKER BROS. ADVISORS LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13F
Company
|
9.4%
|
$13,061,500
5,224,600 shares
|
— | 30 Jun 2023 |
| EcoR1 Capital, LLC |
3/4/5
13F
10%+ Owner · Company
|
9%
from 13F
|
$24,842,500
5,000,000 shares
|
— | 26 May 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
7.2%
|
$10,000,000
4,000,000 shares
|
— | 30 Jun 2023 |
| BVF INC/IL |
13F
Company
|
5.4%
|
$7,473,685
2,989,474 shares
|
— | 30 Jun 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
5%
|
$6,961,980
2,784,792 shares
|
— | 30 Jun 2023 |
| VANGUARD GROUP INC |
13F
Company
|
2.4%
|
$3,398,223
1,359,289 shares
|
— | 30 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
32
Shares
28,588,231
Rows available
32
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
28
Q3 2023 holders
32
Holder diff
4
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 value | Q3 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend